Concepedia

E. G. Clayton

EG

Statistics

Publications

7

Citations

302

H-Index

7

Active since

1995

Affiliations

AstraZeneca (United Kingdom)(Current)

E. G. Clayton is an author at AstraZeneca (United Kingdom) specializing in mass spectrometry, analytical chemistry, and pharmacology.

Publications per year

1995–2016

7

Publications

7

A combined magnetic sector–time‐of‐flight mass spectrometer for structural determination studies by tandem mass spectrometry

Robert Bateman, M. R. Green, E. G. Clayton · Rapid Communications in Mass Spectrometry · 1995 · 73 citations

Pharmacy, Chemistry, Analytical Chemistry +16

Exact Mass Measurement of Polar Organic Molecules at Low Resolution Using Electrospray Ionization and a Quadrupole Mass Spectrometer

Andrew N. Tyler, E. G. Clayton, Brian N. Green · Analytical Chemistry · 1996 · 67 citations

Natural Sciences, Chemistry, Analytical Chemistry +15

<sup>19</sup>F-NMR and directly coupled HPLC-NMR-MS investigations into the metabolism of 2-bromo-4- trifluoromethylaniline in rat: a urinary excretion balance study without the use of radiolabelling

Graeme Scarfe, Brian Wright, E. G. Clayton et al. · Xenobiotica · 1998 · 57 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

The application of high performance liquid chromatography, coupled to nuclear magnetic resonance spectroscopy and mass spectrometry (HPLC-NMR-MS), to the characterisation of ibuprofen metabolites from human urine

E. G. Clayton, S. Taylor, Brian Wright et al. · Chromatographia · 1998 · 54 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Depsidones from Lichens as Natural Product Inhibitors of M-Phase Phosphoprotein 1, a Human Kinesin Required for Cytokinesis

Sandeep K. Talapatra, Oliver Rath, E. G. Clayton et al. · Journal of Natural Products · 2016 · 20 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

1–5 of 7